These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4796581)

  • 1. Proceedings: Rationale and results of primary endocrine therapy in patients with prostatic cancer.
    Scott WW
    Cancer; 1973 Nov; 32(5):1119-25. PubMed ID: 4796581
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Cancer of the prostate.
    Murphy GP
    Cancer; 1973 Nov; 32(5):1089-91. PubMed ID: 4127978
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential test systems for drugs against prostatic cancer.
    Sandberg AA; Kirdani RY; Yamanaka H; Varkarakis MJ; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):175-84. PubMed ID: 1131803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of endocrine manipulation in the treatment of prostatic cancer.
    Neumann F
    Prog Clin Biol Res; 1985; 185A():73-98. PubMed ID: 3898136
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal treatment of advanced cancer of the prostate].
    de Leval J
    Rev Med Liege; 1991 Nov; 46(11):577-82. PubMed ID: 1754776
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiandrogens and prostatic tumours (experimental base and clinical use).
    Neumann R; Schenck B; Senge T; Richter KD
    Prog Clin Biol Res; 1976; 6():169-88. PubMed ID: 66688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cryoimmunology and prostatic cancer].
    Sesia G
    J Urol Nephrol (Paris); 1977; 83 Suppl 2():416-7. PubMed ID: 617704
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-androgenic therapy for prostate carcinoma].
    Schoonees R
    S Afr Med J; 1973 May; 47(17):722-4. PubMed ID: 4702294
    [No Abstract]   [Full Text] [Related]  

  • 9. Castration--chemotherapy treatment of prostate cancer model.
    Drago JR; Worgul TJ; Gallagher C
    J Surg Res; 1981 Apr; 30(4):338-42. PubMed ID: 7194949
    [No Abstract]   [Full Text] [Related]  

  • 10. "Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
    Furr BJ
    Horm Res; 1989; 32 Suppl 1():69-76. PubMed ID: 2533159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some new approaches to potential test systems for drugs against prostatic cancer.
    Sandberg AA; Müntzing J; Kadohama N; Karr JP; Sufrin G; Kirdani RY; Murphy GP
    Cancer Treat Rep; 1977; 61(2):289-95. PubMed ID: 17467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential test systems for chemotherapeutic agents against prostatic cancer.
    Sandberg AA
    Vitam Horm; 1975; 33():155-88. PubMed ID: 820067
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
    Donn F; Becker H; Klosterhalfen H; Klein H
    Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Value of cyproterone in the treatment of prostatic cancers with metastases].
    Bracci U
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):405-6. PubMed ID: 4804409
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate adenocarcinoma model: Nb rat chemotherapy.
    Drago JR; Gershwin ME; Goldman LB
    Surg Forum; 1979; 30():558-9. PubMed ID: 538694
    [No Abstract]   [Full Text] [Related]  

  • 17. New principles in the management of metastatic prostatic cancer.
    Isaacs JT
    Prog Clin Biol Res; 1985; 185A():383-405. PubMed ID: 4034581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of 5-fluorouracil on prostatic DNA synthesis.
    Sloan WR; Coffey DS; Scott WW
    Invest Urol; 1975 Sep; 13(2):90-4. PubMed ID: 1184343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The endocrine profile in prostatic cancer: therapeutic implications].
    Calvo Mateo MA; Castellanos Llorens JM; Galán Ortega A
    Actas Urol Esp; 1981; 5(1):3-12. PubMed ID: 7015803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.